People / Staff

Susana Rives Solà

Search publications

Publications

  • SÍLVIA MARTÍNEZ NADAL, IÑAKI ALCORTA LOYOLA, Estella J, Rives-Solà S and Toll T.

    Anemia hemolítica autoinmune con prueba de antiglobulina positiva a complemento.

    ANALES DE PEDIATRIA . 59(3): 294-296.

    [doi:10.1016/s1695-4033(03)78181-8]

  • Colomo L, López-Guillermo A, Perales M, Rives-Solà S, Martínez A, Bosch F, Colomer D, Falini B, Montserrat E and Campo E.

    Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

    Blood . 101(1): 78-84. Number of citations: 296

    [doi:10.1182/bllod-2002-04-1286]

  • Rives-Solà S, Pera M, Rosiñol L, Vidal O, Miquel R, Solé M, García-Valdecasas J and Bladé J.

    Primary systemic amyloidosis presenting as a colonic stricture: successful treatment with left hemicolectomy followed by autologous hematopoietic stem-cell transplantation: report of a case.

    DISEASES OF THE COLON & RECTUM . 45(9): 1263-1266.

    [doi:10.1097/01.DCR.0000027123.43584.5B]

  • Martínez C, Carreras E, Rovira M, Urbano-Ispizua A, Esteve J, Fernández-Avilés F, Perales M, Rives-Solà S, Gómez M and Montserrat E.

    Allogenic stem cell transplantation as salvage therapy for patients relapsing after autologous transplantation: experience from a single institution.

    LEUKEMIA RESEARCH . 25(5): 379-384. Number of citations: 3

    [doi:10.1016/S0145-2126(00)00146-6]

  • Villela L, López-Guillermo A, Montoto S, Rives-Solà S, Bosch F, Perales M, Ferrer A, Esteve J, Colomo L, Campo E and Montserrat E.

    Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens.

    CANCER . 91(8): 1557-1562. Number of citations: 22

    [doi:10.1002/1097-0142(20010415)91:8<1557::AID-CNCR1165>3.3.CO;2-W]

  • Bladé J, Esteve J, Rives-Solà S, Martínez C, Rovira M, Urbano-Ispizua A, Marín P, Carreras E and Montserrat E.

    High-dose therapy autotransplantation/intensification vs continued standard chemotherapy in multiple myeloma in first remission. Results of a non-randomized study from a single institution

    BONE MARROW TRANSPLANTATION . 26(8): 845-849. Number of citations: 45

    [doi:10.1038/sj.bmt.1702622]

  • Rives-Solà S, Bladé J, Martínez C, Marín P, Carreras E and Montserrat E.

    High dose melphalan therapy with stem-cell support in primary systemic amyloidosis

    MEDICINA CLINICA . 115(6): 216-220. Number of citations: 3

    [doi:10.1016/S0025-7753(00)71514-4]

  • Alvarez A, Rives-Solà S, Montoto S, Sanz C and Pereira A.

    Relative sensitivity of direct antiglobulin test, antibody's elution and flow cytometry in the serologic diagnosis of immune hemolytic transfusion reactions.

    HAEMATOLOGICA . 85(2): 186-188. Number of citations: 9

  • Rives-Solà S, Carreras E, Rovira M, Montoto S, Urbano-Ispizua A, Martínez C, Perales M, Alvarez A, Esteve J, González M and Montserrat E.

    Trasplante autogénico de progenitores hemopoyéticos en régimen ambulatorio: análisis de viabilidad en el Hospital Clínic de Barcelona.

    MEDICINA CLINICA . 113(6): 201-204. Number of citations: 2

  • Espert JJ, Targarona EM, Cervantes F, Bombuy E, Rives-Solà S, Balagué C, Perales M, Nomdedeu B, Montserrat E and Trias M.

    La esplenectomía laparoscópica como alternativa a la intervención quirúrgica convencional en el tratamiento de las plaquetopenias de origen autoinmune.

    MEDICINA CLINICA . 111(14): 525-528. Number of citations: 3